Kati Erdmann

15PUBLICATIONS
44CO-AUTHORS
Medical biochemistry - amino acids and metabolitesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 25, 2024
Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy.

Bjoern Thorben Buerk, Cathrin Kusiek, Vayda Schüttke

|Jul 13, 2024
Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance.

Kati Erdmann, Florian Distler, Sebastian Gräfe

|Oct 30, 2023
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions.

Benedikt Hoeh, Cristina Cano Garcia, Severine Banek

|Sep 11, 2023
Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors.

Vayda Schüttke, Cathrin Kusiek, Susanne Fuessel

|Jan 08, 2023
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.

Dinah Linke, Lukas Donix, Claudia Peitzsch

|Aug 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.

Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer

Pageof 3

Frequent Collaborators

5 joint publications

Susanne Füssel

2 joint publications

Pauline Wimberger

2 joint publications

Jan Dominik Kuhlmann

2 joint publications

Johannes Huber